Following this procedure, patients are typically prescribed topical steroids to help control inflammation, alongside close monitoring of intraocular pressure and pain management in the early postoperative period. In selected cases, the treatment may be repeated cautiously, depending on the eye’s response and residual pressure control.
The success rate of cyclophotocoagulation varies depending on the technique used and the underlying indication. Traditional transscleral cyclophotocoagulation (TSCPC) has shown an intraocular pressure (IOP) reduction success rate ranging from 50% to 80%. Cyclo G6 offers similar efficacy in lowering IOP but is associated with a better safety profile and fewer postoperative complications, making it a preferred option in eyes with some visual potential.